Global risk management in patients with type 2 diabetes mellitus.

by: MH Davidson

The American journal of cardiology, Vol. 99, No. 4A. (19 February 2007)

View FullText article

DOI, Pubmed, Hubmed

Reviews [Write a review of this article]

There are no reviews of this article

Find related articles from these CiteULike users

jyuh

Find related articles with these CiteULike tags

no-tag

Abstract

It is well established that aggressive risk factor modification results in improved cardiovascular disease (CVD) outcomes. Yet, patients with type 2 diabetes mellitus have a much higher baseline risk for cardiovascular events. As type 2 diabetes and hypertension commonly coexist, achieving recommended targets for diabetes, hypertension, and CVD requires aggressive management. Global risk reduction with aggressive low-density lipoprotein reduction and through the additional normalization of glucose levels and blood pressure can help to reduce absolute risk in this very high-risk population.

@article{citeulike:2775028, abstract = {It is well established that aggressive risk factor modification results in improved cardiovascular disease (CVD) outcomes. Yet, patients with type 2 diabetes mellitus have a much higher baseline risk for cardiovascular events. As type 2 diabetes and hypertension commonly coexist, achieving recommended targets for diabetes, hypertension, and CVD requires aggressive management. Global risk reduction with aggressive low-density lipoprotein reduction and through the additional normalization of glucose levels and blood pressure can help to reduce absolute risk in this very high-risk population.}, address = {Rush University Medical Center, Chicago, Illinois 60612, USA. michaeldavidson@radiantresearch.com}, author = {Davidson, M. H. }, citeulike-article-id = {2775028}, doi = {10.1016/j.amjcard.2006.11.005}, issn = {0002-9149}, journal = {The American journal of cardiology}, month = {February}, number = {4A}, posted-at = {2008-05-09 10:31:00}, priority = {2}, title = {Global risk management in patients with type 2 diabetes mellitus.}, url = {http://dx.doi.org/10.1016/j.amjcard.2006.11.005}, volume = {99}, year = {2007} }

RIS record

TY - JOUR ID - citeulike:2775028 L3 - citeulike-article-id:2775028 TI - Global risk management in patients with type 2 diabetes mellitus. JF - The American journal of cardiology VL - 99 IS - 4A AD - Rush University Medical Center, Chicago, Illinois 60612, USA. michaeldavidson@radiantresearch.com SN - 0002-9149 N2 - It is well established that aggressive risk factor modification results in improved cardiovascular disease (CVD) outcomes. Yet, patients with type 2 diabetes mellitus have a much higher baseline risk for cardiovascular events. As type 2 diabetes and hypertension commonly coexist, achieving recommended targets for diabetes, hypertension, and CVD requires aggressive management. Global risk reduction with aggressive low-density lipoprotein reduction and through the additional normalization of glucose levels and blood pressure can help to reduce absolute risk in this very high-risk population. AU - Davidson, MH PY - 2007/02/19/ UR - http://dx.doi.org/10.1016/j.amjcard.2006.11.005 ER -

RIS BibTeX